Comprehensive Guide to Prader-Willi Syndrome: Diagnosis, Care, and Long-Term Management
On this page
What is Prader-Willi Syndrome?
Prader-Willi syndrome (PWS) is a rare, complex genetic condition that affects many parts of the body. It is caused by the loss of function of genes in a specific region of chromosome 15 (15q11.2-q13) that are normally active only on the copy inherited from the father. This parent-specific gene activity is called genomic imprinting — PWS was the first imprinting disorder ever identified.
The estimated incidence is approximately 1 in 15,000 to 21,000 births. PWS occurs through three main genetic mechanisms:
Paternal deletion (60–70% of cases) — a segment of the father's chromosome 15 is missing
Maternal uniparental disomy (20–30% of cases) — the child inherits two copies of chromosome 15 from the mother and none from the father
Imprinting defects (1–3% of cases) — the father's genes are present but silenced
Identifying the specific genetic mechanism is important because it affects recurrence risk for future pregnancies and may influence certain aspects of the clinical presentation.
How Does Prader-Willi Syndrome Change Over Time?
PWS follows a distinctive developmental trajectory. One of the most important things to understand is that the nutritional and behavioral features evolve through well-defined phases:
Nutritional phases
Phase 0 (prenatal): Decreased fetal movements and lower birth weight compared to unaffected siblings
Phase 1a (birth to ~9 months): Severe hypotonia (low muscle tone) with poor suck and difficulty feeding; some infants require tube feeding; failure to thrive may occur
Phase 1b (~9 to 25 months): Feeding and appetite improve; the infant grows steadily along a growth curve
Phase 2a (~2 to 4.5 years): Weight begins to increase without a significant change in appetite or caloric intake
Phase 2b (~4.5 to 8 years): Appetite and interest in food increase, but the child can still feel full
Phase 3 (~8 years to adulthood): Hyperphagia — an intense, persistent drive to eat with rarely feeling full; food-seeking behavior becomes a major concern
Phase 4 (some adults): The appetite becomes more manageable, and some individuals can feel full
Understanding these phases helps families and caregivers prepare for and manage the evolving nutritional challenges.
What are the Features of Prader-Willi Syndrome?
PWS affects multiple body systems. Not every individual will have all features, and severity varies.
Facial features and physical characteristics
Narrow forehead
Almond-shaped eyes
Thin upper lip with downturned mouth
Small hands and feet
Unusually fair skin and light-colored hair (in some individuals, particularly those with the deletion subtype)
Growth and body composition
Short stature (due to growth hormone deficiency)
Decreased lean body mass (muscle) with increased fat mass
Central obesity (abdomen, buttocks, thighs) if diet is not carefully managed
The prevalence of obesity increases with age — from almost none in early childhood to over 90% in adulthood if unmanaged
Endocrine (hormonal)
Growth hormone deficiency — present in nearly all individuals
Hypogonadism — present in nearly all individuals; manifests as genital hypoplasia (undescended testes and small penis in males; underdeveloped labia in females), incomplete puberty, and infertility in most cases
Central hypothyroidism — occurs in up to 30% of children
Central adrenal insufficiency — rare but important to recognize, especially during physiologic stress or illness
Type 2 diabetes — develops in up to 25% of adults with obesity
Premature adrenarche (early pubic hair) or, less commonly, precocious puberty
Neurodevelopment and cognition
Mild to moderate intellectual disability (average IQ approximately 60–70, but ranges widely)
Delayed motor milestones and speech development
Learning disabilities
Relative strengths in reading and visual-spatial skills; relative weaknesses in math and short-term memory
Behavior and mental health
Temper outbursts, stubbornness, and difficulty with transitions — these become more apparent with age
Obsessive-compulsive behaviors — including hoarding, need for sameness, and repetitive questioning
Skin picking — highly prevalent and can cause significant wounds and infections
Anxiety
Emotional lability and difficulty regulating emotions
Risk of psychosis — particularly in adolescents and young adults with the maternal uniparental disomy subtype; annual screening is recommended
Some individuals show features of autism spectrum disorder
Gastrointestinal — IMPORTANT SAFETY INFORMATION
Delayed gastric emptying is present in 60–80% of individuals
Vomiting is rare in PWS (absent in 80–90% of individuals) — this means that when vomiting does occur, it is a serious warning sign
Abdominal distention, bloating, pain, lethargy, loss of appetite, or vomiting may indicate life-threatening gastric inflammation, necrosis, or rupture — seek emergency medical evaluation immediately
Constipation is common
Use of antidiarrheal medications can lead to severe colonic distention, necrosis, and rupture — use with extreme caution
Sleep
Sleep-disordered breathing is very common, including obstructive sleep apnea, central sleep apnea, and nocturnal hypoventilation
Excessive daytime sleepiness affects more than half of adults, even after sleep-disordered breathing is treated
Some individuals develop narcolepsy-like phenotypes
Sleep disorders can significantly impact behavior, cognition, and quality of life
Musculoskeletal
Scoliosis (curvature of the spine) — found in up to 74% of adults
Hip dysplasia
Osteoporosis — increased risk due to hypogonadism, low muscle mass, and decreased physical activity
Eyes
Strabismus (crossed eyes) is common
Dental
Thick, sticky saliva and dry mouth
Enamel defects and increased risk of cavities
Frequent dental hygiene and products for dry mouth are recommended
Other
High pain threshold — injuries or illness may not be reported
Temperature instability — difficulty regulating body temperature
How is Prader-Willi Syndrome Diagnosed?
PWS should be suspected in any infant with unexplained hypotonia and poor feeding. The clinical features that should prompt genetic testing vary by age:
Newborn: Hypotonia with poor suck
1 month to 2 years: Hypotonia with poor suck history plus developmental delay
2 to 6 years: Above features plus developmental delay
6 to 12 years: Above features plus excessive eating with central obesity (if uncontrolled)
13 years to adulthood: Cognitive impairment, excessive eating/hyperphagia with central obesity, hypogonadism, and/or typical behavioral features
Genetic testing
The first-tier test is DNA methylation analysis (such as methylation-specific PCR or MS-MLPA). This test detects an abnormal methylation pattern at the SNRPN gene and identifies more than 99% of individuals with PWS, regardless of the underlying genetic mechanism.
If methylation analysis is abnormal, additional testing is needed to determine the specific molecular subtype:
Oligo-SNP combination array (OSA) — can identify deletions and some forms of uniparental disomy
DNA polymorphism analysis — distinguishes uniparental heterodisomy from imprinting defects
MS-MLPA — can identify deletions and abnormal methylation but cannot distinguish UPD from epimutation
Identifying the molecular subtype is essential for accurate genetic counseling about recurrence risk.
How is Prader-Willi Syndrome Managed?
There is no cure for PWS, but comprehensive management significantly improves health outcomes and quality of life. Management is lifelong and requires coordination among multiple specialists.
Nutrition and weight management (the cornerstone of PWS care)
Begin dietary monitoring when weight percentiles start increasing (typically around age 18–36 months)
Caloric needs are typically 60–80% of the recommended daily allowance for age
Adult energy requirements rarely exceed 1,200–1,400 calories per day
A well-balanced, low-calorie diet with regular exercise is essential
Close supervision to minimize food stealing — locking the kitchen, refrigerator, and cupboards is often necessary once the child can access them
Maintain BMI z-score below 2
Adequate vitamin and mineral intake, especially calcium and vitamin D
Gastric bypass surgery is NOT recommended — it does not correct the lack of satiety, will not prevent overeating, and complication rates are high
Consultation with a dietitian experienced with PWS is strongly recommended
Growth hormone therapy
GH therapy is a central component of PWS management
Benefits include: normalized height, increased lean body mass, decreased fat mass, improved mobility, and — when started in the first year of life — improved motor and cognitive development
Treatment can be started in infancy or at time of diagnosis; many experts recommend starting between 3 and 12 months of age
A genetic diagnosis should be confirmed before starting treatment, but growth hormone stimulation testing is not required
A sleep study (polysomnography) is recommended before starting GH therapy and again 4–8 weeks after starting, to ensure GH has not caused or worsened sleep-disordered breathing
Monitor growth velocity, head circumference, and serum IGF-1 to avoid overtreatment
GH therapy should be continued into adulthood (at a reduced dose, approximately 20–25% of the childhood dose) to maintain muscle mass and body composition
Hypogonadism
Individualized hormone replacement therapy at puberty and beyond, directed by endocrinology
Consider the possibility of osteoporosis and (rarely) fertility in the treatment plan
Hormonal and/or surgical treatment for cryptorchidism
Other endocrine management
Monitor free T4 and TSH every 6–12 months for hypothyroidism
Assess for central adrenal insufficiency as clinically indicated (especially during illness or physiologic stress)
Screen for type 2 diabetes with HbA1c and/or glucose tolerance testing in adolescents and those with obesity or rapid weight gain
Treat precocious puberty if present
Sleep management
Polysomnography before and after starting GH therapy
Annual assessment for sleep issues
Treatment of obstructive sleep apnea with CPAP/BiPAP or adenotonsillectomy (note: adenotonsillectomy may cause velopharyngeal insufficiency in PWS — discuss with ENT)
Modafinil may be helpful for excessive daytime sleepiness that persists after sleep-disordered breathing is treated
Pitolisant has evidence that it is an effective treatment for excessive daytime sleepiness in PWS
Behavioral management
Structured, predictable daily routines with advance warning of transitions
Applied behavioral analysis (ABA) and other behavioral strategies
Topiramate or N-acetylcysteine for skin picking
SSRIs may help reduce skin picking, compulsivity, and aggressive episodes in some individuals
Annual screening for psychosis in adolescents and adults — atypical antipsychotics may be needed for psychotic features or extreme aggression
Distinguish behavioral problems from psychiatric illness — this distinction is critical for appropriate treatment
Musculoskeletal
Standard treatment for scoliosis per orthopedist
Monitoring and treatment of hip dysplasia
Calcium and vitamin D supplementation; sex steroid therapy, GH, or bisphosphonates for low bone density
Gastrointestinal precautions
Educate all caregivers that vomiting is rare in PWS and should be treated as a medical emergency
Abdominal distention, pain, lethargy, or vomiting requires urgent medical evaluation — radiographic imaging and possibly emergency surgery may be needed
Avoid antidiarrheal medications due to risk of severe colonic complications
Dental care
Products for dry mouth (saliva substitutes, sugar-free gum)
Frequent dental hygiene visits
Developmental support
Early intervention services beginning in infancy
Speech therapy, occupational therapy, and physical therapy
Special education services with individualized education plans (IEPs)
Social skills training
Recommended Ongoing Surveillance
The following monitoring schedule is recommended:
At every visit
Development, growth, skin (for skin picking wounds), sleep issues, and family needs
Height, weight, and BMI: monthly in infancy, every 6 months until age 10, then annually
Annually
Testicular position in males (until descent is confirmed or treated)
Behavioral assessment (starting after age 2)
Psychosis screening
Vision assessment
Sleep assessment
Scoliosis screening
Every 6–12 months
Free T4 and TSH
As indicated
HbA1c and/or glucose tolerance test (in adolescents, those with obesity, or rapid weight gain)
Central adrenal insufficiency assessment (during illness or physiologic stress)
Bone density screening (especially in adults)
Sleep study before and after starting GH therapy
Important Precautions
Food environment
Food access must be carefully controlled at all times — at home, school, work, and in the community
All caregivers, teachers, and support staff must understand that individuals with PWS cannot regulate their own food intake
Food-related behavioral crises are best prevented through environmental control rather than willpower
Illness and surgery
Individuals with PWS may not report pain normally due to high pain threshold — monitor for signs of illness or injury even without complaints
Central adrenal insufficiency may require stress-dose steroids during illness or surgery — discuss with endocrinologist
Inform all surgical and anesthesia teams about the PWS diagnosis, including risks of sleep-disordered breathing, hypotonia, and temperature instability
Emergency signs — seek immediate medical attention for
Vomiting (rare in PWS and always concerning)
Abdominal distention or severe abdominal pain
Lethargy or sudden loss of appetite
Signs of respiratory distress
Genetic Counseling and Family Planning
Most cases of PWS are de novo (new) — neither parent is affected
Sibling recurrence risk is typically less than 1%, but may be higher in certain situations:
If the affected individual has a deletion caused by a parental chromosomal rearrangement (translocation), recurrence risk may be up to 25–50%
If the affected individual has an imprinting center deletion inherited from the father, recurrence risk is up to 50%
If the affected individual has maternal UPD, recurrence risk is very low but may be slightly increased with advanced maternal age
Once the molecular subtype is identified, prenatal testing and preimplantation genetic testing are available for future pregnancies
Genetic counseling is recommended for all families
Transition to Adulthood
The transition from pediatric to adult care is a critical period for individuals with PWS. Key considerations include:
Continuation of GH therapy into adulthood (at reduced dose) to maintain body composition
Ongoing dietary supervision and food environment control
Residential placement in a PWS-specialized group home may help regulate behavior and weight management and prevent morbid obesity
Guardianship and legal planning
Vocational training and supported employment
Ongoing medical surveillance for obesity-related complications, type 2 diabetes, sleep disorders, scoliosis, osteoporosis, and psychiatric illness
Obesity and its complications are the major causes of morbidity and mortality in adults with PWS — annual mortality in adults is approximately 3%
Resources
Prader-Willi Syndrome
Prader-Willi Syndrome Association (USA) — National organization providing family support, research funding, crisis intervention, and educational resources; maintains a clinical advisory board and provider directory
Foundation for Prader-Willi Research — Nonprofit dedicated to funding PWS research, including clinical trials and therapeutic development; provides family resources and a research registry
International Prader-Willi Syndrome Organisation (IPWSO) — Global network of PWS associations providing international resources, caregiver guides, and professional education
GeneReviews: Prader-Willi Syndrome — Expert-authored clinical summary including diagnosis, management, and surveillance recommendations
MedlinePlus: Prader-Willi Syndrome — National Library of Medicine resource with patient-friendly overviews of genetics, features, and inheritance
NORD (National Organization for Rare Disorders) — Disease-specific information, patient assistance programs, and connections to clinical experts
Genetic and Rare Diseases Information Center (GARD) — NIH-supported resource with detailed information and links to clinical trials
Growth Hormone and Endocrine Care
MAGIC Foundation — Nonprofit supporting families of children with growth disorders, including PWS-specific resources
Sleep Disorders
American Academy of Sleep Medicine — Professional society with patient education resources and a sleep center finder tool
Genetic Testing and Counseling
National Society of Genetic Counselors — Directory to locate a board-certified genetic counselor
ClinicalTrials.gov — Search for active clinical trials related to Prader-Willi syndrome
Behavioral and Mental Health Support
The Arc — National organization advocating for and serving people with intellectual and developmental disabilities
General Rare Disease Support
Global Genes — Rare disease patient advocacy organization providing resources, community connections, and support programs
Questions? Talk with Dr. Duis
Dr. Duis provides comprehensive, whole-person care for complex and rare conditions through our concierge practice. Explore concierge care or contact us.
This guide is for general education and is not medical advice. Talk with your own healthcare provider about your situation. If you are experiencing a medical emergency, call 911.
